Geriatric assessment for oncologists: Rationale and future directions

被引:64
作者
Hurria, Arti
Lachs, Mark S.
Cohen, Harvery J.
Muss, Hyman B.
Kornblith, Alice B.
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, New York, NY USA
[3] Duke Univ, New York, NY USA
[4] VA Med Ctr, New York, NY USA
[5] Univ Vermont, New York, NY USA
[6] Dana Farber Canc Inst, New York, NY USA
关键词
geriatric assessment; older patient; geriatric oncology;
D O I
10.1016/j.critrevonc.2006.03.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sixty percent of all cancer occurrences and seventy percent of cancer mortalities occur in people over the age of 65. As the population ages. there is an emerging need to develop a means for oncologists to characterize the "functional age" of older patients with cancer in order to tailor treatment decisions and stratify outcomes based on factors other than chronological age and to develop interventions to optimize cancer treatment. In this paper, we discuss the formulation of a geriatric assessment for older patients with cancer. The measures included in this assessment were chosen based on their validity, reliability, brevity, adaptability for self-administration, and ability to prognosticate risk for morbidity or mortality in an older patient. The proposed geriatric assessment covers the essential domains of assessment predictive of survival in the geriatric population, is primarily self-administered, and limited personnel time is required. Our eventual goal is to determine if this geriatric assessment measure can identify factors independent of age that predict cancer treatment morbidity and mortality and result in rationale interventions to optimize oncologic care. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:211 / 217
页数:7
相关论文
共 58 条
[1]   SURVIVAL DETERMINANTS IN EXTENSIVE-STAGE NON-SMALL-CELL LUNG-CANCER - THE SOUTHWEST-ONCOLOGY-GROUP EXPERIENCE [J].
ALBAIN, KS ;
CROWLEY, JJ ;
LEBLANC, M ;
LIVINGSTON, RB .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (09) :1618-1626
[2]  
[Anonymous], [No title captured]
[3]  
[Anonymous], EVALUATION CHEMOTHER
[4]  
AVORN J, 1997, GERIATRIC MED, P55
[5]   Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy [J].
Bajorin, DF ;
Dodd, PM ;
Mazumdar, M ;
Fazzari, M ;
McCaffrey, JA ;
Scher, HI ;
Herr, H ;
Higgins, G ;
Boyle, MG .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3173-3181
[6]  
Balducci L, 2001, Cancer Control, V8, P1
[8]   Sealing of postoperative axillary leakage after axillary lymphadenectomy using a fibrin glue coated collagen patch: a prospective randomised study [J].
Berger, A ;
Tempfer, C ;
Hartmann, B ;
Kornprat, P ;
Rossmann, A ;
Neuwirth, G ;
Tulusan, A ;
Kubista, E .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 67 (01) :9-14
[9]   INFLUENCE OF AGE AND COMORBIDITY ON TREATMENT CHOICE AND SURVIVAL IN ELDERLY PATIENTS WITH BREAST-CANCER [J].
BERGMAN, L ;
DEKKER, G ;
VANKERKHOFF, EHM ;
PETERSE, HL ;
VANDONGEN, JA ;
VANLEEUWEN, FE .
BREAST CANCER RESEARCH AND TREATMENT, 1991, 18 (03) :189-198
[10]   THE INFLUENCE OF AGE ON TREATMENT CHOICE AND SURVIVAL OF ELDERLY BREAST-CANCER PATIENTS IN SOUTH-EASTERN NETHERLANDS - A POPULATION-BASED STUDY [J].
BERGMAN, L ;
KLUCK, HM ;
VANLEEUWEN, FE ;
CROMMELIN, MA ;
DEKKER, G ;
HART, AAM ;
COEBERGH, JWW .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (8-9) :1475-1480